We postulate that elevated levels of Wnt5a during obesity (released from the VAT) may promote the development and growth of the aggressive squamous subtype of PDAC through YAP-mediated mechanisms, although further studies are needed to confirm this model. Here, WNT5A is linked to obesity disorder.